Aligned Genetics Inc (238120) — Financial Flexibility Index

Latest as of September 2025: -0.21x

Aligned Genetics Inc (238120) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of ₩-2.00 Billion (operating CF ₩-2.04 Billion minus capex ₩41.78 Million) represents 0% of total liabilities (₩9.61 Billion). Also explore net asset growth rate of Aligned Genetics Inc to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.21x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩-2.00 Billion
Operating CF − Capex

Total Liabilities

₩9.61 Billion
KRW

Capital Expenditures

₩41.78 Million
KRW

Aligned Genetics Inc Financial Flexibility Index (2015–2024)

Historical Financial Flexibility Index trend for Aligned Genetics Inc across 10 annual periods. Check strategic asset allocation of Aligned Genetics Inc to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Aligned Genetics Inc (2015–2024)

Year-by-year free cash flow to debt coverage for Aligned Genetics Inc. For the full company profile including market capitalisation, see how much is Aligned Genetics Inc worth.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2024 0.39x ₩3.41 Billion ₩3.07 Billion ₩8.78 Billion ▲ +0.1%
2023 0.39x ₩3.73 Billion ₩2.85 Billion ₩9.62 Billion ▼ -26.1%
2022 0.52x ₩4.22 Billion ₩2.22 Billion ₩8.05 Billion ▲ +13.9%
2021 0.46x ₩3.44 Billion ₩135.97 Million ₩7.48 Billion ▲ +1300.5%
2020 0.03x ₩132.11 Million ₩35.67 Million ₩4.02 Billion ▼ -87.0%
2019 0.25x ₩920.91 Million ₩659.29 Million ₩3.65 Billion ▲ +134.7%
2018 -0.73x ₩-1.53 Billion ₩-1.75 Billion ₩2.11 Billion ▼ -156.9%
2017 -0.28x ₩-471.30 Million ₩-876.75 Million ₩1.67 Billion ▼ -72.4%
2016 -0.16x ₩-275.21 Million ₩-1.14 Billion ₩1.68 Billion ▼ -278.6%
2015 0.09x ₩73.12 Million ₩-351.72 Million ₩796.04 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities